LXM-27205-21878
2 vaccinations
3 coded responses
23 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 786 / TX
- Registered
- 2021-09-14
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-14
Registered in v-safe
-
2021-09-14
Dose 1 — Pfizer-BioNTech
-
2021-09-14
Survey response — day 0, dose 1MedDRA: Immediate post-injection reaction, Vision blurred — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Blurred vision right after receiving the shot. Went away in 20 minutes.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-16
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort — Feeling: Fair · Fatigue or tirednessFree text: Chest tightnessMedDRA releases: 2024-11 · check-in free text available
- 2021-09-17
- 2021-09-18
- 2021-09-19
- 2021-09-20
- 2021-09-21
- 2021-09-28
-
2021-10-05
Dose 2 — Pfizer-BioNTech
- 2021-10-05
-
2021-10-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
-
2021-10-19
Survey response — day 14, dose 2MedDRA: Dizziness, Dyspnoea, Speech disorder, Vision blurred — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Shortness of breath. Dizziness. Blurred vision. Impaired speech.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-22
Call successfulDoes not wish to fill out VAERS report
- 2021-10-26
- 2021-11-04
- 2021-11-09
- 2021-11-16
- 2022-01-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-14 | Pfizer-BioNTech | No |
| 2 | 2021-10-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Blurred vision right after receiving the shot. Went away in 20 minutes.
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Chest tightness
Release 10 — day 14, dose 2
Symptoms: Shortness of breath. Dizziness. Blurred vision. Impaired speech.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Speech disorder | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SRO | Chest discomfort | · | · | ✓ |
| SRO | Immediate post-injection reaction | · | · | ✓ |
| SRO | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release